Pathstone Holdings
LH icon

Pathstone Holdings’s Labcorp LH Stock Holding History

Pathstone Holdings’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Sell
11,388
-1,169
-9% -$307K 0.01% 862
2026
Q1 		$3.35M Buy
12,557
+1,188
+10% +$322K 0.01% 748
2025
Q4 		$2.85M Sell
11,369
-2,242
-16% -$595K 0.01% 848
2025
Q3 		$3.91M Buy
13,611
+2,375
+21% +$636K 0.01% 655
2025
Q2 		$2.95M Sell
11,236
-171
-1% -$41.6K 0.01% 778
2025
Q1 		$2.66M Buy
11,407
+1,110
+11% +$269K 0.01% 824
2024
Q4 		$2.36M Buy
10,297
+132
+1% +$30.3K 0.01% 885
2024
Q3 		$2.27M Buy
10,165
+5,637
+124% +$1.24M 0.01% 900
2024
Q2 		$921K Sell
4,528
-6,420
-59% -$1.31M ﹤0.01% 1377
2024
Q1 		$2.39M Buy
10,948
+1,563
+17% +$344K 0.01% 828
2023
Q4 		$2.13M Buy
+9,385
New +$1.97M 0.01% 719

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pathstone Holdings's LH Position: Q2 2026 in Review

Pathstone Holdings reduced its Labcorp (LH) stake by 9.3% in Q2 2026, selling an estimated $307K and leaving 11,388 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #862.

Pathstone Holdings first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.91M in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Pathstone Holdings held 11,388 shares of Labcorp worth $3.19M as of Q2 2026.
  • Pathstone Holdings sold 1,169 Labcorp shares in Q2 2026, an estimated $307K.
  • Labcorp made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #862 holding.
  • Pathstone Holdings first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Labcorp position peaked at $3.91M in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.